While the key genes for fatty acid synthesis and uptake were not significantly changed, suggesting that TET1 inhibits NAFLD by promoting fatty acid oxidation via PPARα pathway. This evidence concerns the gene TET1 and metabolic dysfunction-associated steatotic liver disease.